MedPath

Efficacy of niacin on phosphatic metabolism in patients with renal insufficiency

Conditions
Exam the efficacy of niaspan in phosphate metabolism of patients with renal insufficiency, different exam for dialysis and predialysis patients
Registration Number
EUCTR2005-002221-31-DE
Lead Sponsor
Clinic for Nephrology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

age 18-90
chronic renal insufficiency
stable dose of calcium-containing phosphatbinding medication for the last four weeks
blood pressure<180/100mmHg

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

intake from niacin during the last six months
dose-change for lipid-lowering therapy in the last six weeks
another clinical trial in the last 30 days
known drug use
pregnancy
known allergic reaction to niacin
liver function disturbances
lack of cooperation

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: phosphate and calcium metabolism;Secondary Objective: lipid metabolism;Primary end point(s): change in the serum phosphate level
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath